GLP-1 inhibits gastric emptying of water but does not influence plasma.

BACKGROUND Glucagon-like peptide-1 (GLP-1) has been shown to inhibit gastric emptying of a caloric load but the effect on a non-caloric load is unknown. METHODS Seven healthy men were studied after an over-night fast. Thirty min before the intake of 330 ml radioactively labeled water either GLP-1 (0.75 pmol/kg/min) or saline was administered intravenously and continued for 75 min. Scintigraphic gastric emptying was performed for 45 min and plasma samples were obtained for analysis of vasopressin, sodium, osmolality, GLP-1, insulin, and glucose. In addition, electric field stimulation of human gastric muscle strips was done. RESULTS The median (range) percent water retained in the stomach, 45 min after intake of water, was 96% (68%-98%) and 12% (2%-42%) (P = 0.02) during infusion of GLP-1 and saline, respectively. Additionally, GLP-1 did not affect basal tone or contractile response of gastric muscle strips to electric field stimulation or acetylcholine (ACh). There was no change in plasma concentrations of vasopressin, sodium, or plasma osmolality during GLP-1 compared to saline infusion. CONCLUSION GLP-1 has a profound inhibitory effect on the gastric emptying of water in man, but no short-term effect on water homeostasis. No effect was seen on contractility of gastric muscle strips suggesting an indirect action on gastric emptying.

[1]  J. Holst,et al.  GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. , 1999, The American journal of physiology.

[2]  E. Blázquez,et al.  Coexpression of Glucagon‐Like Peptide‐1 (GLP‐1) Receptor, Vasopressin, and Oxytocin mRNAs in Neurons of the Rat Hypothalamic Supraoptic and Paraventricular Nuclei , 1999, Journal of neurochemistry.

[3]  D Conen,et al.  Glucagon-like peptide-1: a potent regulator of food intake in humans , 1999, Gut.

[4]  J. Holst,et al.  Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[5]  G. Edwards,et al.  Glucagon-Like Peptide-1 (7–36) Amide Administered into the Third Cerebroventricle Inhibits Water Intake in Rats , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  S. Rössner,et al.  Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. , 1998, The American journal of clinical nutrition.

[7]  S. Bloom,et al.  Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes. , 1998, Clinical science.

[8]  J. Dunphy,et al.  Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression 1 This work was supported by a grant from the Crohn's and Colitis Foundation of America. 1 , 1998, Molecular and Cellular Endocrinology.

[9]  A. Astrup,et al.  Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. , 1998, The Journal of clinical investigation.

[10]  C. Beglinger,et al.  Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. , 1998, The Journal of endocrinology.

[11]  B. Yeğen,et al.  Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[12]  J. Holst,et al.  Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. , 1997, Scandinavian journal of gastroenterology.

[13]  E. Näslund,et al.  Seven year results of vertical banded gastroplasty for morbid obesity. , 1997, The European journal of surgery = Acta chirurgica.

[14]  E. Blázquez,et al.  Colocalization of Glucagon‐Like Peptide‐1 (GLP‐1) Receptors, Glucose Transporter GLUT‐2, and Glucokinase mRNAs in Rat Hypothalamic Cells: Evidence for a Role of GLP‐1 Receptor Agonists as an Inhibitory Signal for Food and Water Intake , 1996, Journal of neurochemistry.

[15]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[16]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[17]  J. Holst,et al.  Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects , 1995, Diabetes.

[18]  J. Holst,et al.  Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  B. Göke,et al.  Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. , 1995, Digestion.

[20]  J. Holst,et al.  Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans , 1994, Diabetes.

[21]  P. Gross,et al.  Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Zinsmeister,et al.  Relation between antral motility and gastric emptying of solids and liquids in humans. , 1985, The American journal of physiology.

[23]  M. Horowitz,et al.  Gastric emptying in normal subjects--a reproducible technique using a single scintillation camera and computer system. , 1983, Gut.

[24]  G. Bell,et al.  Hamster preproglucagon contains the sequence of glucagon and two related peptides , 1983, Nature.

[25]  K. Kelly,et al.  Gastric emptying of liquids and solids: roles of proximal and distal stomach. , 1980, The American journal of physiology.